For context on what realistic expectations look like with incretin therapy, the weight loss timeline data provides month-by-month benchmarks that users can compare against their own progress
Cerebrolysin is not FDA-approved in the United States and remains investigational, so it is presented for educational context only and not as a treatment
doi:10.1016/S0140-6736(23)01163-7
Mike Israetel is 40 years old, and hes looking damn good for it
77 On the other hand, in two similar studies using a preclinical canine IVD degeneration model, the intradiscal delivery of either nonsteroidal (celecoxib, selective COX2 inhibitor) or steroidal antiinflammatory (triamcinolone acetonide) drug release by a microsphere platform was able to reduce NGF expression in the IVD
It doesn't stop degradation entirelynothing canbut it slows it to a crawl, extending the useful life of your research compound from mere hours or days to several weeks